Phenobarbital is the most widely used anti-seizure medication for dogs, and while it’s effective at controlling epilepsy, it comes with a recognizable set of side effects. Most are mild and temporary, appearing in the first weeks of treatment and fading as your dog’s body adjusts. A smaller number are serious and require monitoring over the long term, particularly effects on the liver and blood cells.
Common Early Side Effects
The side effects most dog owners notice first are sedation, increased appetite, increased thirst, and increased urination. These tend to appear within the first week or two of starting treatment. Your dog may seem groggy, unsteady on their feet, or less interested in their usual activities. Some dogs lose interest in their morning meals early on, even as their overall appetite increases over time.
Ataxia, a wobbly or uncoordinated gait, is one of the most frequently reported side effects. Research published in Frontiers in Veterinary Science found that ataxia severity is closely tied to the dosage and the period right around the start of treatment. Owners consistently rate ataxia and sedation as the most burdensome side effects, not just for the dog but for their own quality of life as caretakers. The good news: most dogs develop tolerance to sedation and clumsiness within a few weeks as their body adapts to steady drug levels.
Occasional loose stools can occur but are generally isolated episodes rather than a persistent problem.
Weight Gain and Polyphagia
Phenobarbital increases appetite significantly in many dogs. This effect doesn’t fade the way sedation does. Dogs on long-term treatment will often beg for food, scavenge, or eat far more than they did before starting the medication. Without portion control and regular exercise, weight gain is common and can become substantial over months and years. If your dog is gaining weight steadily, adjusting food intake early is far easier than trying to reverse obesity later.
Liver Effects: What’s Harmless vs. What’s Not
Phenobarbital is processed by the liver, and it stimulates the liver to produce higher levels of certain enzymes. This means that routine blood work on a dog taking phenobarbital will almost always show elevated liver enzyme levels, specifically ALP, ALT, and GGT. This is one of the most misunderstood aspects of the drug, because those elevated numbers often reflect the liver working harder to metabolize the medication, not actual liver damage.
A study in the Journal of Veterinary Internal Medicine confirmed that increases in ALP, ALT, and GGT in dogs on phenobarbital often reflect enzyme induction rather than hepatic injury. The researchers found that other markers, including AST, fasting bile acids, and bilirubin, are not affected by this enzyme-induction effect. These tests, along with liver ultrasound, give a more accurate picture of whether the liver is actually being harmed. So if your vet runs blood work and your dog’s ALP is high, that alone isn’t cause for alarm. But if bile acids or bilirubin start climbing, that’s a different conversation.
True liver toxicity from phenobarbital does happen, though it’s uncommon. Signs to watch for include vomiting, loss of appetite, jaundice (yellowing of the gums or whites of the eyes), fluid buildup in the abdomen, and unusual lethargy. These warrant immediate veterinary attention. Regular blood monitoring, typically every 6 to 12 months once a dog is stable on the medication, helps catch problems before they become critical.
Blood Cell Disorders
Rare but serious, phenobarbital can suppress the bone marrow’s ability to produce blood cells normally. A study examining dogs with phenobarbital-related blood disorders found that affected dogs developed low counts across multiple cell types: red blood cells, white blood cells, and platelets. Of the 13 dogs in the study, eight had pancytopenia (all three cell lines affected), while others had combinations of anemia and low platelet or white blood cell counts.
The hallmark finding was ineffective blood cell production. The bone marrow was actively trying to make cells but failing to release them properly. In dogs with low white blood cell counts, the median time to recovery after stopping phenobarbital was about 14 days. The researchers noted that these blood disorders should be suspected in any dog on phenobarbital that develops abnormalities across multiple blood cell types, particularly when neutropenia (low infection-fighting white blood cells) is present alongside evidence that the marrow is overproducing but underdelivering.
Symptoms you might notice at home include unusual bruising, pale gums, prolonged bleeding from minor cuts, lethargy beyond what’s expected from the drug, or frequent infections. These signs call for immediate blood work.
Drug Interactions
Phenobarbital is metabolized by liver enzymes in the cytochrome P450 family, which makes it vulnerable to interactions with other medications that use or block those same pathways. Fluconazole, a commonly prescribed antifungal, inhibits several of these enzymes and can impair phenobarbital metabolism. This causes phenobarbital levels in the blood to rise, potentially into the toxic range, even if the dose hasn’t changed. Two documented cases in dogs involved this exact interaction.
Phenobarbital can also speed up the metabolism of other drugs your dog takes, making them less effective. If your dog needs any new medication, whether for an infection, pain, or another condition, the prescribing vet needs to know about the phenobarbital.
Serum Level Monitoring
The therapeutic range for phenobarbital blood concentration in dogs is 15 to 40 micrograms per milliliter. Below 15, seizures are less likely to be controlled. Above 45, the risk of toxicity climbs significantly. Vets typically check serum levels two to three weeks after starting the drug or changing the dose, then periodically thereafter. If levels are below the target and seizures continue, the dose is usually increased by about 20% at a time rather than making large jumps.
Because phenobarbital’s metabolism can change over time (the liver gets more efficient at breaking it down), a dose that worked well initially may need adjustment months or years later. Consistent monitoring catches this drift before seizures return.
Risks of Stopping Suddenly
Phenobarbital creates physical dependence, and abruptly stopping the medication can trigger withdrawal seizures, including potentially life-threatening clusters or status epilepticus (a seizure that doesn’t stop on its own). The highest risk period for seizure recurrence is during the withdrawal process itself and the days immediately following.
When discontinuation is appropriate, vets typically taper the dose gradually over one to three months. Even with careful tapering, there’s a real possibility that seizures will return and may be harder to control with medication than they were before. This is an important consideration: once a dog starts phenobarbital, stopping it is not straightforward, and owners should understand that restarting treatment may not restore the same level of seizure control the dog previously had.